Carlo has been with Pfizer for 12 years having joined the organization as part of the Pharmacia/Sugen merger in 2003. Currently, he is ClinPharm team leader for the dacomitinib full development program in non-small cell lung cancer as well as the neratinib breast cancer program. He is directing the clinical pharmacology components of the dacomitinib program as well as overseeing the design and conduct of the ClinPharm needed for regulatory registration. Previously as a key member of the Sutent team, he was instrumental in the worldwide regulatory approvals for Renal Cell Carcinoma and Gastrointestinal Stromal tumor. Carlo is also the Global ClinPharm representative on the Pfizer Pediatric Safety Council.
From 2012-2013, Global Health Fellows will work with the Infectious Diseases Institute (IDI) research team in Uganda to assess and strengthen their capacity to run Phase I-IV clinical trials following global standards. Fellows will assist the clinical trials unit on all aspects of management structure, including developing standard operating procedures on data & quality measures & training materials. They will assist on all aspects of managing trials including developing operating procedures, implementing data & quality measures & training staff. Fellows work will contribute to IDI's goal of being the premier service provider for patients with infectious diseases.
From his Fellowship experience, Carlo hopes to gain a better understanding of the challenges to treating HIV/AIDS in Uganda. Working with the IDI, he hopes to leverage his experience to improve the conduct of clinical trials and apply his training in pharmacology to share learnings with team members. Carlo believes this valuable hands-on experience will help him to design and conduct clinical trials upon his return.
Accordia Global Health Foundation is working to overcome the burden of infectious diseases by building health care capacity and strengthening academic medical institutions in Africa. Accordia does this through establishing Centers of Excellence for advancing and promoting the highest quality standards of infectious disease care through original research and healthcare workforce training. The Infectious Disease Institute (IDI) in Kampala, Uganda is Accordia's flagship program. Created via public-private partnership and multi-institutional collaboration, IDI serves as a model for sustainable, locally-owned, regional centers of excellence. IDI offers high quality training for health workers; research on best practices related to HIV in low resource settings; and advanced clinical services that support the development of new models of care.